Know Cancer

or
forgot password
  • cancer clinical trials in dallas, TX

  • Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    Texas Oncology, PA at Texas Cancer Center Dallas Southwest
    Dallas, Texas 75237
    Prostate Cancer
    Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
    Medical City Dallas Hospital

    Trial Locations
    Medical City Dallas Hospital
    Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
    Kidney Cancer
    Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
    University of Texas Southwestern Medical Center
    Dallas, Texas
    Adult Alveolar Soft-part Sarcoma, Adult Angiosarcoma, Adult Epithelioid Sarcoma, Adult Extraskeletal Chondrosarcoma, Adult Extraskeletal Osteosarcoma, Adult Fibrosarcoma, Adult Leiomyosarcoma, Adult Liposarcoma, Adult Malignant Fibrous Histiocytoma, Adult Malignant Hemangiopericytoma, Adult Malignant Mesenchymoma, Adult Neurofibrosarcoma, Adult Synovial Sarcoma, Childhood Alveolar Soft-part Sarcoma, Childhood Angiosarcoma, Childhood Epithelioid Sarcoma, Childhood Fibrosarcoma, Childhood Leiomyosarcoma, Childhood Liposarcoma, Childhood Malignant Mesenchymoma, Childhood Neurofibrosarcoma, Childhood Synovial Sarcoma, Chondrosarcoma, Dermatofibrosarcoma Protuberans, Localized Childhood Malignant Fibrous Histiocytoma of Bone, Metastatic Childhood Malignant Fibrous Histiocytoma of Bone, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
    Medical City Dallas Hospital

    Trial Locations
    Medical City Dallas Hospital
    University of Texas Southwestern Medical Center
    Stage I Wilms Tumor, Stage II Wilms Tumor, Stage III Wilms Tumor
    Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
    Medical City Dallas Hospital

    Trial Locations
    Medical City Dallas Hospital
    Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
    Leukemia, Myelodysplastic Syndromes
    A Study of Tarceva After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors
    Texas Oncology, P.A.

    Trial Locations
    Texas Oncology, P.A.
    Texas Oncology
    Texas Oncology Texas Cancer Center at Medical City
    Non-small Cell Lung Cancer
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Medical City Dallas Hospital

    Trial Locations
    Medical City Dallas Hospital
    Presbyterian Hospital of Dallas
    Breast Cancer
    Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor
    University of Texas Southwestern Medical Center
    Dallas, Texas
    Untreated Childhood Medulloblastoma, Untreated Childhood Pineoblastoma, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
    Medical City Dallas Hospital

    Trial Locations
    Medical City Dallas Hospital
    University of Texas Southwestern Medical Center
    Contiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, T-cell Adult Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer
    Medical City Dallas Hospital

    Trial Locations
    Medical City Dallas Hospital
    Texas Oncology, PA at Texas Cancer Center Dallas Southwest
    Anal Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Medical City Dallas Hospital

    Trial Locations
    Medical City Dallas Hospital
    Parkland Memorial Hospital
    Zale Lipshy University Hospital
    University of Texas Southwestern Medical Center
    Saint Paul Hospital
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases
    University of Texas Southwestern Medical Center
    Dallas, Texas
    Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Chronic Myelogenous Leukemia, Childhood Myelodysplastic Syndromes, Chronic Phase Chronic Myelogenous Leukemia, de Novo Myelodysplastic Syndromes, Juvenile Myelomonocytic Leukemia, Previously Treated Myelodysplastic Syndromes, Recurrent Childhood Acute Lymphoblastic Leukemia, Secondary Myelodysplastic Syndromes
    Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia in Remission
    Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
    Dallas, Texas 75390
    Leukemia
    Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
    Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
    Dallas, Texas 75390
    Ototoxicity, Unspecified Childhood Solid Tumor, Protocol Specific
    Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors
    Medical City Dallas Hospital
    Dallas, Texas 75230
    Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Ovarian Cancer, Testicular Germ Cell Tumor
    Safety Study of Infusion of SGT-53 to Treat Solid Tumors
    Mary Crowley Medical Research Center
    Dallas, Texas 75246
    Neoplasm
    A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
    Pediatric Allergy/Immunology Associates

    Trial Locations
    Pediatric Allergy/Immunology Associates
    Dermatology Treatment and Research Center, PA
    Pushpa R. Rana M.D. P.A.
    Atopic Dermatitis
    Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
    University of Texas Southwestern Medical Center
    Dallas, Texas
    Endometrial Cancer
    Adj TC + Herceptin Early Stage Breast Cancer
    Texas Oncology, P.A.

    Trial Locations
    Texas Oncology, P.A.
    Texas Cancer Center at Medical City
    Texas Oncology PA
    Methodist Charlton Cancer Ctr.
    Breast Cancer
    TAC Versus TC for Adjuvant Breast Cancer
    Texas Cancer Center at Medical City

    Trial Locations
    Texas Cancer Center at Medical City
    Texas Oncology PA
    Methodist Charlton Cancer Ctr.
    Breast Cancer
    Randomized Phase 3b Study in Previously Untreated Multiple Myeloma Patients: VELCADE,Thalidomide, and Dexamethasone Versus VELCADE and Dexamethasone Versus VELCADE, Melphalan, and Prednisone
    Texas Oncology, P.A.

    Trial Locations
    Texas Oncology, P.A.
    Texas Oncology
    Texas Oncology, PA
    Dallas Oncology Consultants
    Texas Oncology PA
    Texas Oncology, PA / Methodist Charlton Cancer Center
    Multiple Myeloma
    Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery
    Zale Lipshy University Hospital

    Trial Locations
    Zale Lipshy University Hospital
    University of Texas Southwestern Medical Center
    Saint Paul Hospital
    HER2-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer